Literature DB >> 7952498

Ultrastructural localization of P-glycoprotein on capillary endothelial cells in human gliomas.

Y Tanaka1, Y Abe, A Tsugu, Y Takamiya, A Akatsuka, T Tsuruo, H Yamazaki, Y Ueyama, O Sato, N Tamaoki.   

Abstract

The P-glycoprotein (P-Gp) encoded by the human multidrug-resistance gene MDR1 has been suggested to play certain roles in the blood-brain barrier (BBB). However, the detailed mechanism of the activity of P-Gp in multidrug-resistance (MDR) remains unclear in human glioma. We examined the localization of P-Gp in human glioma by immunohistochemical (IHC) and immunoelectron microscopic (IEM) methods with anti P-Gp monoclonal antibodies (C219, MRK16). We also examined MDR1 expression in primary glioma and xenografts by reverse transcription-polymerase chain reaction (RT-PCR) with human MDR1-specific primers. The IHC study showed no P-Gp expression on tumour cells but it was present on capillary endothelial cells and IEM analysis showed definitive localization on their luminal surface. MDR1 gene expression was detected in eight primary glioma and three normal brain specimens by RT-PCR, but not in glioma xenografts. The lack of MDR1 expression in these cells appears to be a consequence of the replacement of the original human stroma, including blood vessels, by murine stroma in glioma xenografts. The unique distribution of P-Gp on the capillary blood vessels was confirmed in human glioma by the results of immunohistochemical and molecular biological studies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7952498     DOI: 10.1007/BF00230349

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  34 in total

1.  Expression of P-glycoprotein in human glioma cell lines and surgical glioma specimens.

Authors:  T Matsumoto; E Tani; K Kaba; H Shindo; K Miyaji
Journal:  J Neurosurg       Date:  1991-03       Impact factor: 5.115

2.  Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies.

Authors:  H Hamada; T Tsuruo
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

3.  Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.

Authors:  F Thiebaut; T Tsuruo; H Hamada; M M Gottesman; I Pastan; M C Willingham
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

4.  Differential overexpression of three mdr gene family members in multidrug-resistant J774.2 mouse cells. Evidence that distinct P-glycoprotein precursors are encoded by unique mdr genes.

Authors:  S I Hsu; L Lothstein; S B Horwitz
Journal:  J Biol Chem       Date:  1989-07-15       Impact factor: 5.157

5.  Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16.

Authors:  I Sugawara; I Kataoka; Y Morishita; H Hamada; T Tsuruo; S Itoyama; S Mori
Journal:  Cancer Res       Date:  1988-04-01       Impact factor: 12.701

6.  Expression of a multidrug resistance gene in human cancers.

Authors:  L J Goldstein; H Galski; A Fojo; M Willingham; S L Lai; A Gazdar; R Pirker; A Green; W Crist; G M Brodeur
Journal:  J Natl Cancer Inst       Date:  1989-01-18       Impact factor: 13.506

7.  In vivo acquired drug resistance and multidrug resistance gene (MDR1) expression in the KB carcinoma cell line xenotransplanted in nude mice.

Authors:  Y Abe; M Nakamura; R Saegusa; Y Ueyama; T Ogata; N Tamaoki
Journal:  Tokai J Exp Clin Med       Date:  1993-12

8.  Intrinsic drug resistance in human kidney cancer is associated with expression of a human multidrug-resistance gene.

Authors:  A T Fojo; D W Shen; L A Mickley; I Pastan; M M Gottesman
Journal:  J Clin Oncol       Date:  1987-12       Impact factor: 44.544

Review 9.  Chemotherapy for malignant gliomas.

Authors:  P L Kornblith; M Walker
Journal:  J Neurosurg       Date:  1988-01       Impact factor: 5.115

10.  Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction.

Authors:  K E Noonan; C Beck; T A Holzmayer; J E Chin; J S Wunder; I L Andrulis; A F Gazdar; C L Willman; B Griffith; D D Von Hoff; I B Roninson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

View more
  12 in total

Review 1.  Functional expression and localization of P-glycoprotein in the central nervous system: relevance to the pathogenesis and treatment of neurological disorders.

Authors:  Gloria Lee; Reina Bendayan
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

2.  Inhibition of P-glycoprotein: rapid assessment of its implication in blood-brain barrier integrity and drug transport to the brain by an in vitro model of the blood-brain barrier.

Authors:  L Fenart; V Buée-Scherrer; L Descamps; C Duhem; M G Poullain; R Cecchelli; M P Dehouck
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

3.  P-glycoprotein is strongly expressed in the luminal membranes of the endothelium of blood vessels in the brain.

Authors:  E Beaulieu; M Demeule; L Ghitescu; R Béliveau
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

4.  MDR1 P-glycoprotein is expressed by endothelial cells of newly formed capillaries in human gliomas but is not expressed in the neovasculature of other primary tumors.

Authors:  K Tóth; M M Vaughan; N S Peress; H K Slocum; Y M Rustum
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

5.  Drug resistance-associated factors in primary and secondary glioblastomas and their precursor tumors.

Authors:  D S Tews; A Nissen; C Külgen; A K Gaumann
Journal:  J Neurooncol       Date:  2000-12       Impact factor: 4.130

6.  Rapid induction of long-lasting drug efflux activity in brain vascular endothelial cells but not malignant glioma following irradiation.

Authors:  U Andersson; K Grankvist; A T Bergenheim; P Behnam-Motlagh; H Hedman; R Henriksson
Journal:  Med Oncol       Date:  2002       Impact factor: 3.064

7.  Expression and functional activity of the ABC-transporter proteins P-glycoprotein and multidrug-resistance protein 1 in human brain tumor cells and astrocytes.

Authors:  Sabine Spiegl-Kreinecker; Johanna Buchroithner; Leonilla Elbling; Elisabeth Steiner; Gabriele Wurm; Angelika Bodenteich; Johannes Fischer; Michael Micksche; Walter Berger
Journal:  J Neurooncol       Date:  2002-03       Impact factor: 4.130

8.  Mrp4 confers resistance to topotecan and protects the brain from chemotherapy.

Authors:  Markos Leggas; Masashi Adachi; George L Scheffer; Daxi Sun; Peter Wielinga; Guoqing Du; Kelly E Mercer; Yanli Zhuang; John C Panetta; Brad Johnston; Rik J Scheper; Clinton F Stewart; John D Schuetz
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

9.  Murine P-glycoprotein on stromal vessels mediates multidrug resistance in intracerebral human glioma xenografts.

Authors:  Y Takamiya; Y Abe; Y Tanaka; A Tsugu; M Kazuno; Y Oshika; K Maruo; Y Ohnishi; O Sato; H Yamazaki; H Kijima; Y Ueyama; N Tamaoki; M Nakamura
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  Quantitative PCR analysis of the expression profile of genes related to multiple drug resistance in tumors of the central nervous system.

Authors:  Elvis Terci Valera; Agda Karina Brodoloni Lucio-Eterovic; Luciano Neder; Carlos Alberto Scrideli; Helio Rubens Machado; Carlos Gilberto Carlotti-Junior; Rosane Gomes de Paula Queiroz; Fabio José do Nascimento Motta; Luiz Gonzaga Tone
Journal:  J Neurooncol       Date:  2007-04-12       Impact factor: 4.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.